http://proteases-inhibitors.co....m/assessment-as-well
Background and objective Liver transplantation (LT) may be the gold-standard treatment plan for end-stage liver disease; nevertheless, late-onset problems such as fatty liver can happen within the absence of metabolic comorbidities. We report a unique instance of post-transplant hepatic steatosis developing in only an integral part of the liver graft. Case report A 1-year-old kid underwent ABO-incompatible lifestyle donor liver transplantation (LDLT) with a left lateral liver graft donated fro
Like
Comment
Share
